Atopic Dermatitis (AD)
Conditions
Interventions
Intervention type:
Name of intervention:ECM-E
Dose form / Japanese Medical Device Nomenclature:TABLET
Route of administration / Site of application:ORAL
Dose per administration:900,1200
mg
Dosing freq
Sponsors
ADAPTGEN PHARMACEUTICAL CO.LTD.
Hirose Clinic,MEDOC Medical Dock&Clinic,Sanbongi Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: *Age: a patient who is 4 to 44 years old at the time of Informed Consent *Sex: don't ask *hospitalization and visitors *Disease: The patient who is diagnosed with atopic dermatitis based on the Japanese Dermatological Association atopic dermatitis clinical practice guideline and who wishes to treat or under medical treatment.
Exclusion criteria
Exclusion criteria: 1) - Contact dermatitis - Seborrheic dermatitis - Prurigo simplex - scabies - Heat rash - Fishskin disease - Leather fat deficiency eczema - Hand eczema (in order to except hand eczema other than atopic dermatitis), and a cutaneous lymphoma - Psoriasis - The disease by immunity deficiency - Collagen disease (SLE,Dermatomyositis) - Nether ton syndrome 2) Patient which have allergies in chicken 3)Mucopolysaccharidosis 4) The woman and nursing mother who wish to become pregnant during pregnancy or exam time 5)Those who have been suffered from critical liver and renal damage, and cardiac disease 6)The patient who has critical complications 7)Those who participated in other clinical tests within the past three months 8)The patient considered to be disqualified by judgment of the doctor who examines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The improvement evaluation of atopic dermatitis severity The improvement evaluation according to the judgment of the degree of itchy | — |
Countries
Japan
Contacts
Public ContactToru Urakawa
ADAPTGEN PHARMACEUTICAL CO.LTD.
Outcome results
None listed